Schizophrenia Trials in Rochester, United States
Conditions / Schizophrenia / Rochester, United States
Schizophrenia is a medical condition with active clinical research programs worldwide.
79 total trials for this combination
Showing top 10 of 79 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00731549 | Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia | COMPLETED | PHASE3 |
| NCT01129882 | An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia | COMPLETED | PHASE3 |
| NCT00102518 | Aripiprazole Open-Label, Safety and Tolerability Study | COMPLETED | PHASE3 |
| NCT02161718 | A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder | COMPLETED | PHASE2 |
| NCT05145413 | A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | COMPLETED | PHASE3 |
| NCT01716975 | Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT00014001 | CATIE- Schizophrenia Trial | COMPLETED | PHASE4 |
| NCT05304767 | An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | RECRUITING | PHASE3 |
| NCT00528905 | Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia | COMPLETED | PHASE2 |
| NCT01432444 | Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole | COMPLETED | PHASE3 |